US20210386680A1
University of Texas System
1 . A therapeutic nanoparticle comprising stimuli-cleavable crosslinks, and at least one physiologically active agent, wherein the nanoparticle has a particle size of between about 100-1,000 nm, and wherein the nanoparticle undergoes stimulus-directed degradation. 2 . The nanoparticle of claim 1 ,